Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Disulfides × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 4 Gliosarcoma 4 Glioblastoma 4 Brain Neoplasms 3 Ovarian Neoplasms 2 Oligodendroglioma 2 Breast Neoplasms 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Soft Tissue Neoplasms 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Recurrence 1 Prostatic Neoplasms 1 Platinum-Refractory Fallopian Tube Carcinoma 1 Pharyngeal Neoplasms 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neurofibromatosis 2 1 Neoplasms, Mesothelial 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Liposarcoma 1 Leiomyosarcoma 1 Hemangiosarcoma 1 Glioma 1

Interventions

Ifosfamide 29 Methotrexate 27 Doxorubicin 25 Cyclophosphamide 23 Cisplatin 21 Etoposide 16 Filgrastim 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 11 Temozolomide 9 Specimen Handling 9 fludarabine 8 apatinib 8 X-Rays 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Carboplatin 8 Zoledronic Acid 7 Sirolimus 7 Radiotherapy 7 Phantoms, Imaging 7 Drug Therapy 7 Docetaxel 7 Biopsy 7 mifamurtide 6 cabozantinib 6 Vincristine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04668300 2025-10-09

DOSa

M.D. Anderson Cancer Center

Phase 2 Active not recruiting

Hemangiosarcoma, Liposarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡